Search

everythinglearnresearchcommunity

for

Search:↓

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

The monkey's hair loss was due to an autoimmune disease, not genetics.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

No clear link between androgen receptor variation and hair loss, but more research needed.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

A woman with lupus and systemic sclerosis developed severe acne that didn't improve with treatment and died from pneumonia and septic shock.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Permanent hair dye may cause total hair loss.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.